v3.25.2
INCOME TAX - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]    
Capitalized R&D Expenses $ 4,565,699 $ 5,610,221
Other Deferred Items 43,982 44,193
Stock Compensation 437,328 455,192
Net Operating Loss - US 8,349,314 6,161,916
R&D Credits 3,701,895 3,627,377
Net deferred tax assets 17,098,218 15,898,899
Valuation Allowance (17,098,218) (15,898,899)
Net deferred tax assets (liabilities) $ 0 $ 0